LSBCF (LakeShore Biopharma Co) Institutional Ownership: 0.06% (As of Jun. 30, 2026)


What is LakeShore Biopharma Co Institutional Ownership?

LakeShore Biopharma Co LSBCF Institutional Ownership is 0.06% as of Jun. 30, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LakeShore Biopharma Co's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LakeShore Biopharma Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LakeShore Biopharma Co's Float Percentage Of Total Shares Outstanding is 62.34%.

LakeShore Biopharma Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Institutional Ownership Chart

LakeShore Biopharma Co Historical Data

The historical data trend for LakeShore Biopharma Co can be seen below:

2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31 2025-06-30
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01

LakeShore Biopharma Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.06% mean?
LakeShore Biopharma Co (LSBCF) has a Institutional Ownership of 0.06% as of Jun. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Institutional Ownership too high?
LakeShore Biopharma Co's current Institutional Ownership is 0.06%.
How does LakeShore Biopharma Co's Institutional Ownership compare to ACUT and PPCB?
LakeShore Biopharma Co's Institutional Ownership of 0.06% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Institutional Ownership is 0.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Institutional Ownership of 0.06%. The current Institutional Ownership is 0.06%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Institutional Ownership is 0.06% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.